Table 4.
Control Group | Afoxolaner-treated Group | |||
---|---|---|---|---|
Day | Arithmetic (Geometric) Mean | Arithmetic (Geometric) Mean | Percentage efficacy (based on geometric means) | ANOVA p-Value |
Day 2 | 47.3 (47.1) | 0.8 (0.6) | 98.2 (98.7) | < 0.0001 |
Day 8 | 41.7 (41.6) | 0.0 (0.0) | 100.0 (100.0) | < 0.0001 |
Day 15 | 33.7 (32.3) | 3.8 (1.7) | 88.6 (94.7) | < 0.0001 |
Day 22 | 41.3 (40.0) | 8.5 (2.7) | 79.4 (93.4) | 0.0005 |
Day 29 | 49.8 (49.7) | 12.3 (5.0) | 75.3 (89.8) | 0.001 |